BRAF mutations have been found in 29% of these melanomas (Akslen et al, in press), and strong ID1 expression (SI⩾4) was significantly higher among these mutated cases, 71 vs 37% among the others (χ2 test, P=0.04). Here, BRAF is linked to melanoma.